The application of an enzyme-linked immunosorbent assay or an immunofluorescent assay test leads to different estimates of seroprevalence of Coxiella burnetii in the population

Epidemiology and Infection

Volumn 140, Issue 1, 2012, Pages 36-41

  Blaauw, G J ^a,c   Notermans, D W ^b   Schimmer, B ^b   Meekelenkamp, J ^a   Reimerink, J H J ^b   Teunis, P ^b   Schneeberger, P M ^a,b  

^a JEROEN BOSCH HOSPITAL   (Netherlands)

^b NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^c GELRE HOSPITALS   (Netherlands)

Author keywords

Coxiella; ELISA; epidemiology; immunoepidemiology; Q fever

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY;

ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; COXIELLA BURNETII; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDEMIC; EPIDEMIOLOGICAL DATA; HUMAN; IMMUNOFLUORESCENCE TEST; INTERMETHOD COMPARISON; NETHERLANDS; Q FEVER; REFERENCE VALUE; SENSITIVITY AND SPECIFICITY; SEROEPIDEMIOLOGY; SEROPREVALENCE;

COXIELLA BURNETII; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; Q FEVER; REFERENCE VALUES; SEROEPIDEMIOLOGIC STUDIES;

EID: 82455175322     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S0950268811000021     Document Type: Article

References (26)

1. Maurin M, Raoult D. Q fever. Clinical Microbiology Reviews 1999; 12: 518-553. (Pubitemid 29484745)
2. Dupuis G, et al. An important outbreak of human Q fever in a Swiss alpine valley. International Journal of Epidemiology 1987; 16: 282-287. (Pubitemid 17108848)
3. Dupont HT, Thirion X, Raoult D. Q fever serology: cutoff determination for microimmunofluorescence. Clinical and Diagnostic Laboratory Immunology 1994; 1: 189-196. (Pubitemid 2057614)
4. Bartelink AK, et al. Acute and chronic Q fever ; epidemiology, symptoms, diagnosis and therapy of infection caused by Coxiella burnetii [in Dutch]. Nederlands Tijdschrift voor Geneeskunde 2000; 144: 1303-1306.
5. Waag D, et al. Validation of an enzyme immunoassay for serodiagnosis of acute Q fever. European Journal of Clinical Microbiology and Infectious Diseases 1995; 14: 421-427.
6. Fournier PE, Marrie TJ, Raoult D. Diagnosis of Q fever. Journal of Clinical Microbiology 1998; 36: 1823-1834. (Pubitemid 28277760)
7. Kilic S, et al. Prevalence of Coxiella burnetii antibodies in blood donors in Ankara, central Anatolia, Turkey. New Microbiologica 2008; 31: 527-534.
8. Pape M, et al. Seroprevalence of Coxiella burnetii in a healthy population from northern Greece. Clinical Microbiology and Infection 2009; 15: 148-149.
9. Cardenosa N, et al. Short report: Seroprevalence of human infection by Coxiella burnetii in Barcelona (Northeast of Spain). American Journal of Tropical Medicine and Hygiene 2006; 75: 33-35. (Pubitemid 351627567)
10. Bolanos M, et al. Seroprevalence of infection by Coxiella burnetii in Canary Islands (Spain). European Journal of Epidemiology 2003; 18: 259-262. (Pubitemid 36597145)
11. Karagiannis I, et al. Q fever outbreak in the Netherlands: a preliminary report. Eurosurveillance 2007; 12: E0708092.
12. Karagiannis I, et al. Investigation of a Q fever outbreak in a rural area of the Netherlands 2009. Epidemiology and Infection ; 137: 1283-1294.
13. Schimmer B, et al. Large ongoing Q fever outbreak in the south of The Netherlands. Eurosurveillance 2008; 13: pii=18 939.
14. Schimmer B, et al. Sustained intensive transmission of Q fever in the south of the Netherlands, Eurosurveillance 2009; 14: pii=19 120.
15. Schimmer B, et al. Q fever in The Netherlands: an update on the epidemiology and control measures. Eurosurveillance 2010; 15: pii=19 520.
16. Villumsen S, et al. Determination of new cutoff values for indirect immunofluorescence antibody test for Q fever diagnosis in Denmark. Diagnostic Microbiology and Infectious Diseases 2009; 65: 93-98.
17. Cowley R, et al. Enzyme immunoassay for Q fever: comparison with complement fixation and immunofluorescence tests and dot immunoblotting. Journal of Clinical Microbiology 1992; 30: 2451-2455.
18. Peter O, et al. Comparison of enzyme-linked immunosorbent assay and complement fixation and indirect fluorescent-antibody tests for detection of Coxiella burnetii antibody. Journal of Clinical Microbiology 1987; 25: 1063-1067. (Pubitemid 17079592)
19. DHarcourt SC, et al. Comparison of immunofluorescence with enzyme immunoassay for detection of Q fever. European Journal of Clinical Microbiology and Infectious Diseases 1996; 15: 749-752.
20. Field PR, et al. Comparison of a commercial enzymelinked immunosorbent assay with immunofluorescence and complement fixation tests for detection of Coxiella burnetii (Q fever) immunoglobulin M. Journal of Clinical Microbiology 2000; 38: 1645-1647. (Pubitemid 30216705)
21. Field PR, et al. Evaluation of a novel commercial enzyme- linked immunosorbent assay detecting Coxiella burnetii-specific immunoglobulin G for Q fever prevaccination screening and diagnosis. Journal of Clinical Microbiology 2002; 40: 3526-3529. (Pubitemid 34977486)
22. Frangoulidis D, et al. Comparison of four commercially available assays for the detection of IgM phase II antibodies to Coxiella burnetii in the diagnosis of acute Q fever. Annals of the New York Academy of Sciences 2006; 1078: 561-562. (Pubitemid 44968678)
23. Sanz JC, et al. Application of four ELISA techniques (two for IgM and two for IgG) for serological diagnosis of an outbreak of Q fever [in Spanish]. Enfermedades Infecciosas y Microbiologca Clnica 2006; 24: 178-181.
24. Setinoyo A, et al. New Criteria for immunofluorecence assay for Q fever diagnosis in Japan 2005. Journal of Clinical Microbiology; 43: 5555-5559.
25. Slabá K, Skultéty L, Toman R. Efficiency of various serological techniques for diagnosing Coxiella burnetii infection. Acta Virologica 2005; 49: 123-127. (Pubitemid 47046824)
26. Dupuis G, et al. Immunoglobulin responses in acute Q fever. Journal of ClinicalMicrobiology 1985; 22: 484-487. (Pubitemid 15239256)